The bioactive cell secretions utilise the molecules including cytokines and growth factors that are secreted by MSCs and work in concert to reduce pain and inflammation and encourage accelerated healing and repair. The secretions have been developed as a topical application for the treatment of inflammatory skin conditions such as acne and wound healing. Regeneus has developed proprietary technology and protocols for the production of secretions from MSCs.

Strategic Partners

We continue our discussions with parties for the development and commercialisation opportunities for topical applications of our secretions products in both the therapeutic and cosmetic markets.